Xiaojuan Li, PhD, MSPH

Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, United States

Disclosure information not submitted.

Presentation(s):

• 4C-03 - Impact of Roxadustat Approval on Anemia Treatment Patterns in Chinese Patients with Chronic Kidney Disease

  Monday, August 25, 2025
  4:45 PM - 5:00 PM ET

• 6G-02 - Levetiracetam Use and Dementia Risk in Patients with Post-Stroke Seizures: A Population-Based Study Using a Target Trial Emulation Framework

  Tuesday, August 26, 2025
  1:45 PM - 2:00 PM ET